Using our AI model trained on historical data, we generated a 12‑month forecast for Cullinan Oncology Inc. (CGEM) stock. The model estimates a median target price of 0—ranging from a low of 0 to a high of 0—which suggests a decrease of 0% compared to the current price of 8.00.